title: Conformable GORE TAG thoracic endoprosthesis.
abstract: US FDA approval of the conformable Gore TAG thoracic endoprosthesis for multiple indications including aneurysm, traumatic transection and Type B dissection marks significant progress in minimally invasive therapies for the treatment of complex, life-threatening thoracic aortic pathology. This second generation device, with its enhanced flexibility and conformability, is providing improvements in both short- and long-term outcomes for many patients who may otherwise be denied life-saving treatment for thoracic aortic pathology.
authors.affiliation: St. Vincent Heart and Vascular center, Northwestern University, 2900 12th Avenue N, Suite 400E, Billings, MT 59101, USA.
authors.forename: Mark D
authors.initials: MD
authors.lastname: Morasch
mesh_terms: D001013:Aorta, Thoracic / Q000473:pathology / Q000601:surgery*; D001018:Aortic Diseases / Q000473:pathology / Q000601:surgery; D001807:Blood Vessel Prosthesis; D019917:Blood Vessel Prosthesis Implantation / Q000379:methods*; D018795:Device Approval; D057510:Endovascular Procedures / Q000295:instrumentation / Q000379:methods; D006801:Humans; D011474:Prosthesis Design; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration
keywords: aneurysm; aortic endoprothesis; aortic tear; thoracic aorta; type B dissection